A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Condition:   Respiratory Syncytial Virus Infections
Interventions:   Drug: ALS-008176;   Drug: Placebo
Sponsor:   Alios Biopharma Inc.
Completed - verified January 2017